Concepedia

Hewei Li

HL

Statistics

Publications

23

Citations

2.2K

H-Index

16

Active since

1997

Affiliations

Bristol-Myers Squibb (United States)(Current)

Huazhong University of Science and Technology

McGill University

Union Hospital

Beijing University of Chinese Medicine

Hewei Li is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and life sciences.

Publications per year

1997–2022

23

Publications

23

Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma

Jeffrey S. Weber, F. Stephen Hodi, Jedd D. Wolchok et al. · Journal of Clinical Oncology · 2017 · 1.2K citations

, , +17

Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis

James Larkin, Bartosz Chmielowski, Christopher D. Lao et al. · The Oncologist · 2017 · 262 citations · Full text

, , +17

Triptolide Inhibits the Proliferation of Prostate Cancer Cells and Down-Regulates SUMO-Specific Protease 1 Expression

Weiwei Huang, Tiantian He, Chengsen Chai et al. · PLoS ONE · 2012 · 128 citations · Full text

, , +14

Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma.

Hewei Li, Mario Alonso‐Vanegas, Michael A. Colicos et al. · PubMed · 1999 · 81 citations

, , +17

Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats

Hewei Li, Ling Dong, Guopeng Wang et al. · International Journal of Pharmaceutics · 2014 · 70 citations

, , +8

1–5 of 23